Joanne Weidhaas

9PUBLICATIONS
64CO-AUTHORS
Synchrotrons and accelerators not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 27, 2026
Paraspeckles Are Associated with the Activation and Nuclear Localization of Unphosphorylated miR-34a.

|Mar 06, 2026
The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer: Results from the NRG/RTOG 1016 Trial.

Joanne B Weidhaas, Jonathan Harris, Maura L Gillison

|Nov 12, 2025
177Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study.

Amar U Kishan, Luca F Valle, Holly Wilhalme

|Apr 07, 2025
Validation and Derivation of miRNA-Based Germline Signatures Predicting Radiation Toxicity in Prostate Cancer.

Amar U Kishan, Kristen McGreevy, Luca Valle

|Nov 14, 2023
Prediction of Radiation Treatment Response for Locally Advanced Rectal Cancer via a Longitudinal Trend Analysis Framework on Cone-Beam CT.

Zirong Li, Ann C Raldow, Joanne B Weidhaas

|Sep 20, 2023
The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC.

Joanne B Weidhaas, Chen Hu, Ritsuko Komaki

Pageof 2

Frequent Collaborators

2 joint publications

Graham H Read

2 joint publications

Michael Steinberg

2 joint publications

Luca Valle

2 joint publications

Kristen McGreevy